Christine Elizabeth Allan

Title: Christine Elizabeth Allan: Innovator in Benzylamine Derivatives

Introduction

Christine Elizabeth Allan is a notable inventor based in Eastleigh, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her work on benzylamine derivatives. With a total of two patents to her name, her innovations are aimed at improving therapeutic methods for various diseases.

Latest Patents

Christine's latest patents focus on benzylamine derivatives. The present invention provides compounds of formula (I), which include compositions comprising such compounds. These compounds are utilized in therapy, specifically for the treatment or prevention of diseases or conditions where plasma kallikrein activity is implicated. The methods of treating patients with these compounds are also outlined, with specific definitions for R1 to R3, R5 to R9, A, P, V, W, X, Y, and Z as defined in her patents.

Career Highlights

Throughout her career, Christine has worked with Kalvista Pharmaceuticals Limited, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in therapeutic applications, showcasing her expertise in the pharmaceutical industry.

Collaborations

Christine has collaborated with notable individuals such as Andrzej Roman Batt and Rebecca Louise Davie. These collaborations have likely enriched her work and contributed to her success in the field.

Conclusion

Christine Elizabeth Allan is a distinguished inventor whose work on benzylamine derivatives has the potential to impact therapeutic practices significantly. Her contributions to the pharmaceutical industry reflect her dedication to innovation and improvement in patient care.